Barclays Upgrades Strategy to $175, Maintains Buy

Barclays Boosts MicroStrategy Price Target, Reclassifies Firm

Barclays has signaled renewed confidence in MicroStrategy Inc. (NASDAQ: MSTR), with analyst Nik Cremo reaffirming an “Overweight” rating—the bank’s equivalent of a buy recommendation—and raising his 12-month price target to $175 from $160. The adjustment was announced on October 9, 2026.

A Shift in Sector Classification

Perhaps more noteworthy than the price target increase is Barclays’ reclassification of MicroStrategy. The bank now places the company within the U.S. payments and fintech sector, drawing comparisons to industry giants like Visa and Mastercard, rather than solely viewing it as a Bitcoin-centric entity.

Potential Upside and Recent Performance

The new $175 price target suggests a potential upside of approximately 15-16% from recent trading levels. MicroStrategy shares have been trading in a range between $151 and $158. The stock closed at $151.47 on October 8, 2026, and saw modest gains in pre-market trading the following morning as the Barclays report circulated.

Bitcoin Holdings and Financial Reporting

MicroStrategy holds approximately 845,000 Bitcoin as a treasury asset. This significant Bitcoin stash is a defining characteristic of the company and profoundly influences its financial results, sometimes leading to outcomes that may appear unusual at first glance.

In the second quarter, MicroStrategy reported revenue of roughly $122.4 million, marking a 7% increase compared to the same period in the previous year. However, the company’s net results were impacted by unrealized fluctuations in the value of its Bitcoin holdings.

Evolution of Barclays’ Stance

Barclays’ current optimism represents an evolution from its initial coverage of MicroStrategy on July 8, 2026, when it initiated with a price target of $130. Following the company’s second-quarter earnings report, Barclays had trimmed that target to $125. The target subsequently rose to $160 before reaching the current $175 figure, indicating a consistent trend of upward revisions since the post-earnings adjustment.

Analyst Consensus and Divergence

While Barclays has increased its target, it is not the most bullish outlook on Wall Street. Citi has set a price target of $240 for MSTR, and B. Riley’s target stands at $195. This suggests that while analysts generally agree on a positive trajectory for the stock, there are significant differences in their assessments of its potential magnitude.

The 7% revenue growth reported in the second quarter provides support for the argument of a healthy operating business. Nevertheless, the company’s net earnings will continue to be influenced by the performance of Bitcoin.